Embed Size (px)
Citation preview
MEDICAL TECHNOLOGIES IN THE GREATER MONTREAL AREA : A BUOYANT SECTOR OF ACTIVITY
November 2013
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
TABLE OF
CONTENT
EXECUTIVE SUMMARY 3
REASONS TO INVEST IN GREATER MONTREAL 4
An ideal location to conquer the North-American market 5
Montreal, a hub in biomedical research and healthcare-related technologies 6
At the junction of IT and life sciences 8
Industry leaders, news and recent announcements 10
Skilled manpower from a diversified academic environment
An environment conducive to innovation
Incubators, business coaching and counselling 16
University based technology transfer organisations 17
The Quebec National Policy on Research and Innovation (PNRI) 18
A hot spot of open innovation and collaborative research 19
Metropolitan Montreal, a leading Venture Capital center in Canada 20
Competitive financial incentives 21
MONTRÉAL INTERNATIONAL : A PERSONAL TOUCH 24
2
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
3
EXECUTIVE
SUMMARY
Perfect timing for Metropolitan Montreal :
• Up to date medical technologies are needed to improve the quality of healthcare while reducing costs and increasing accessibility in the context of aging population
• The biomedical technology sector is maturing as multinational corporations settle in Montreal following the acquisition of innovative platforms: Medtronic-Cryocath, ZimmerCAS, Elekta, Masimo
• Large investments are currently taking place in three new university hospital complexes
• The healthcare systems of Quebec and of Canada are transiting towards informatics and large scale data management; the electronic patient record is being implemented
A long tradition of excellence in biomedical research and in the execution of clinical trials• The Montreal cluster combines research institutes, public and private laboratories, suppliers,
CROs, service providers and innovative companies, all working in close interaction
A dense network of colleges and universities, including two faculties of medicine, four schools of engineering and numerous research centers renown internationally
Strong support by the Quebec Government to innovation and innovative companies• Implementation of the National Policy on Research and Innovation (PNRI) ( 3,7 G$)
along seven strategic areas including: life science and personalized medicine• Funds for open innovation and projects carried out by research consortia• Highly competitive financial incentives
4
REASONSTO INVEST IN THE GREATER MONTREAL REGION
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
5
THE GREATER MONTREAL AREA:
AN IDEAL SITE TO CONQUERTHE NORTH AMERICAN MARKET
Direct access to the market of the North American Free Trade Agreement (NAFTA), representing approximately
● 460 million consumers
● A total GDP of USD 17 trillion
Signing of the free trade agreement between Canada and the European Union
● Better harmonization of the regulatory process
● Increased commercial trade
Economic engine of Quebec, representing 50% of the population, GDP and employment in the province
● Population : nearly 4 M
● Real GDP (in 2012) : 161 G ($ of 2007)
● Employment : nearly 2 M
A strategic location in North America
• Flying time less than 2 hours from Toronto, Boston and New York
• 70 km from the U.S. border
High quality transportation infrastructure
• Two international airports (Montreal-Trudeau and Montreal-Mirabel)
• One sea port amongst the busiest ports in North America, open all year round and linked to more than 100 countries
• A major logistic hub linking port-rail-road-air
Source : The Conference Board of Canada, 2013
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
6
THE GREATER MONTREAL AREA:
A HUB IN BIOMEDICAL RESEARCHAND HEALTHCARE-RELATED TECHNOLOGIES
LONG TRADITION OF EXCELLENCE
IN BIOMEDICAL RESEARCH
● Cluster made up of world-class universities, research centers and university hospitals
● Internationally renown center for conducting clinical research
● Comprehensive research activities in: Cardiology Neuroscience Oncology Geriatrics Metabolic diseases & nutritional disorders Genetic diseases & genomics Biomedical engineering
EXPERTISE IN ENABLING
TECHNOLOGIES
● Computer graphics and 3D animation
● Medical imaging
● Information technology
● Data management
● Hosting servers and data warehousing
● Systems engineering
● Nanotechnologies & advanced materials
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
7
A HUB IN BIOMEDICAL RESEARCH AND HEALTHCARE SCIENCE
RESEARCH CENTERS AND INSTITUTES
RESEARCH CENTERS LINKED TO HOSPITALS
● Centre de recherche Fernand-Seguin(Institut universitaire en santé mentale de Montréal)
● Centre hospitalier de l'Université de Montréal (CHUM)
● McGill University Health Center (MUHC)
● CHU Sainte-Justine (pædiatric hospital)
● Jewish General Hospital (Lady Davis Institute)
● Hôpital Maisonneuve-Rosemont
● Montreal Children Hospital
● Hôpital du Sacré-Cœur
● Montreal Neurological Institute and Hospital
● Institut Philippe-Pinel de Montréal
Source : Montreal InVivo Interactive Maphttp://www.montreal-invivo.com/web/la-grappe/cartographie/
RESEARCH INSTITUTES
● Centre for interdisciplinary research in Rehabilitation of Greater Montreal (CRIR)
● Montreal Cardiology Institute
● Institut de réadaptation Gingras-Lindsay-de-Montréal (IRGLM)
● Institut de recherches cliniques de Montréal (IRCM)
● Douglas Mental Health University Institute
● Institut de recherche Robert Sauvé en santé et en sécurité du travail du Québec (IRSST)
● Institut du cancer de Montréal (ICM)
● Montreal Chest Institute
● Institut universitaire de gériatrie de Montréal
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
8
THE GREATER MONTREAL AREA:
AT THE JUNCTION OF IT AND LIFE SCIENCES
LIFE SCIENCES AND HEALTH TECHNOLOGIES (LSHT)
● 45,000 employments in 600 establishments
● With more than 12,000 researchers and professionals
● In 300 public agencies and government-own organisations1
● 235 companies including 80 subsidiaries of foreign corporations2
INFORMATION AND COMMUNICATION TECHNOLOGIES (ICT)
● More than 92,000 skilled employees in nearly 5,000 organizations3
● 400 subsidiaries of foreign corporations4
● 12 500 positions in R-D activities5 :
7 500 researchers in centers own by private corporations
5 000 researchers in more than 100 university research centers
1 : Statistics Canada 2012 and Expertise recherche Québec 20122 : http://www.montrealinternational.com/sciences-de-la-vie/3 : Statistics Canada 20124 : http://www.montrealinternational.com/technologies-de-linformation-et-des-communications/5 : http://www.montrealinternational.com/innovation-technologies-de-linformation-et-des-communications/
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
9
THE GREATER MONTREAL AREA:MULTIPLE BRIDGES BETWEEN SECTORS OF THE ECONOMY
CROSS-FERTILISATION
● ICT (Information and Communication Technologies) Telemedecine and e-health
● Video games industry virtual reality, training platforms, improving patient’s experience
● Aeronautics simulators, high precision machining and manufacturing
● Genomics & bio-informatics diagnostics, personalized medicine
● Logistics inventory management, optimization of logistic chains, traceability
MONTREAL, «VILLE UNESCO DU DESIGN»
● A node of the UNESCO cities of design network (2006) – web site
● Unique creativity centre (scenic arts, media arts and technology, industrial design)
● Contribution of design and creativity to the medical technology sector : Ergonomy, 3D simulation, motion tracking and ambient monitoring Improving «patient’s experience», enriched health and life spaces
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
10
A HUB IN BIOMEDICAL RESEARCH AND MEDICAL TECHNOLOGY INDUSTRY LEADERS, NEWS AND ANNOUNCEMENTS
Kinova
· Loan from Invest Québec to support the company’s effort in commercializing its Jaco platform on the U.S. and European markets. The JACO arm, for which the company holds several patents, is the first three-fingered robotic arm designed to increase the functional independence of motorized wheelchair users (October 2013).
Carré Technologies
· Official launching of the intelligent shirt Hexoskin, a high tech garment with integrated sensors that captures body metrics including heart rate and pulse recovery, breathing rate and acceleration. Hexoskin offers an easy and more natural way of regularly capturing precise physiological data (August 2013).
Emovi
· Emovi has signed a distribution agreement for the commercialisation overseas of KneeKG, a unique system used for precisely measuring and documenting the knee joint function in an outpatient setting. The KneeKG provides objective data regarding the function of the knee and highlights deficiencies in gait associated with knee problems (September 2013).
EMcision International
· The company specializing in advanced radiofrequency-based medical devices used in surgery, has announced that it has sold its first units of the Habib™ RF DUO 13 catheter - a new device with immense potential to help abdominal cancer patients (August 2013).
Sources : Flash InVivo http://www.montreal-invivo.com/web/ and corporate internet sites
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
11
A HUB IN BIOMEDICAL RESEARCH AND MEDICAL TECHNOLOGY INDUSTRY LEADERS, NEWS AND ANNOUNCEMENTS (CONT’D)
Medtronic
· In 2012, the company announced an investment of 50 M$ in its Medtronic Cryocath division, more specifically into its R&D Centre, in advanced training resources and in its manufacturing unit. This follows the acquisition by the American multinational of the cryotherapy platform developed in Montreal to treat different heart conditions such as cardiac arryhtmias.
Hoffmann-La Roche and the Montreal Cardiology Institute
· In April 2012, the Montreal Cardiology Institute has been designated a hub for translational medicine devoted to cardiometabolic disease in the global network of the multinational pharmaceutical company Roche. This novel approach aims at transposing results of clinical research into personalized treatments for improving patients’ cardio-vascular health.
Piramal Life Sciences
· Following the acquisition of Biosyntech’s platform on biomaterials, the Indian-based multinational has initiated the commercialisation of BST-CarGel, a novel surgical biopolymer to be used for repairing knee cartilage. The gel, fluid at room temperature, is mixed in an OR setting with aulogous blood and inserted into the patient’s cartilage where it thickens and favours the reconstruction of damaged tissues.
Elekta
· In 2010, the Swedish group Elekta has acquired Resonant Medical, a company that has developed a 3D echography technology to guide precisely radiotherapy equipment during cancer treatment procedures.
Sources : Flash InVivo http://www.montreal-invivo.com/web/ and corporate internet sites
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
12
A HUB IN BIOMEDICAL RESEARCH AND MEDICAL TECHNOLOGY INDUSTRY LEADERS, NEWS AND ANNOUNCEMENTS (CONT’D)
Héma-Québec (web site)
· Héma-Québec's mission is to efficiently provide adequate quantities of safe, optimal blood components, substitutes, human tissues and cord blood to meet the needs of all Quebecers. It provides products and services in the fields of transfusion medicine and human tissue transplantation.
· The only public cord blood bank in Canada, operated by Héma-Québec since 2004, has increased its activities at a sustained pace both nationally and internationally. Since September 2012, Héma-Québec has been offering its cord blood units to the international community through Bone Marrow Donors Worldwide (BMDW).
MEDEC (web site)
· MEDEC is the national association created by and for the Canadian medical technology industry. Its goals are to advance health outcomes for patients in Canada as well as the growth and vibrancy of the industry in Canada while favoring access to proven, safe and innovative medical technology developed by its member companies.
· With an office and increasing presence in Quebec, MEDEC is the primary source for advocacy, information and education on the medical technology industry for members, the greater healthcare community, industry partners and the general public.
· MEDEC strongly supports the recent announcement by the Government of Canada of the successful conclusion of negotiations with the European Union of the surrounding the Comprehensive Economic and Trade Agreement (CETA) which will boost commercial ties between the two partners particularly the healthcare and medical technology sector.
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
13
SKILLED MANPOWER
FROM A DIVERSIFIED ACADEMIC ENVIRONMENT
Sources : Association d’études canadiennes, 2007 ; Ministère de l’Éducation, du Loisir et du Sport (MELS) du Québec, 2011 ; Statistique Canada, 2007 et 2012
A large university network
● 11 academic institutions
● More than 170 000 university students, of which 20 000 foreign students
The largest pool of new university graduates in Canada
40 000 graduates per year
The most multilingual population in Canada
● 50 % is bilingual
● 20 % is multilingual (three languages and more)
Engineering schools: Faculty of Medicine:
École Polytechnique de Montréal University of Montreal & McGill University
École de Technologie Supérieure Management schools:
McGill University HEC Montréal, UQAM,
Concordia University Concordia & McGill
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
14
SKILLED MANPOWER
TRAINING AND RESEARCH IN BIOMEDICAL ENGINEERING
Biomedical Engineering Institute of U de M
• Linked with École Polytechnique and the University of Montreal
Research Objectives:
● Cardiac electrophysiology
● Biomedical signals, systems and imaging
● Biomechanics and biomaterials/ rehabilitation
● Biomedical modelling and simulation
Web site
Research Centre in Biomedical Science and Technologies (GRSTB)
A multidisciplinary regrouping of labs, scientists and engineers from different institutions
Web site
McGill University - Department of Biomedical Engineering
• A pioneer in North America, part of McGill Faculty of Medicine
Research areas:
● Signals, systems and modelling
● Biomaterials and tissue engineering
● Artifical cells and drug delivery systems
● Lab-on-a-chip and biosensors
● Nanoparticles, nanomedecine
● Neuro-imaging
● Personalized medicine
Web site
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
15
SKILLED MANPOWER
TRAINING AND RESEARCH IN BIOMEDICAL ENGINEERING
Biomedical Engineering program of École de technologie supérieure (ETS)
Research axis:
● Biomechanics and biomaterials
● Medical imaging and devices
● Occupational health and safety
● Telehealth, electronic patient records
Enabling technologies:
● Software and informatics
● Nanotechnologies
● Prototyping and manufacturing
● Robotics
● Material science
Web site
Concordia University – Office of research
Research themes:
● Sensors and bio-opto-electronics
● Cardio-vascular diagnostics
● Design, testing and manufacturing
● Cellular imaging
● Lab-on-a-chip and microfluidics; MEMS
● Nanomaterials and drug delivery
● Mass spectrometry applied to biological studies biologie
Web site
Concordia Concordia – Centre PERFORM
● Dedicated to new ways of researching better health through prevention
● Advanced clinical research facility available for multidiciplinary, interinstitutional studies
Web site
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
16
AN ENVIRONMENT CONDUCIVE TO INNOVATION
INCUBATORS, BUSINESS COACHING AND COUNSELLING
CTS (Campus des technologies de la santé)
● CTS provides services, physical facilities, a network of experts and programs for companies of the medical sector developing devices, instruments, systems and IT
Web site
CQIB
● Incubator for companies in LSHT, operated in partnership with Laval Technopole
● Access to infrastructure (equipment and space), to consulting services and business networks, to funding sources
Web site
NRC (Boucherville)
● Provides space for innovative companies● Access to NRC expertise in photonics,
microfluidics and material science
Web site
CENTECH, ETS Business incubator
● Currently has about fifty active businesses
● Accepting projects of students and graduates from the early stage of the entrepreneurial process (emergence phase)
Web site
Centre d’entreprises et d’innovation de Montréal (CEIM)
● CEIM offers customized management consulting and related services for the creation and development of companies
● Sectors: information technology, new media, clean technology and life sciences
Web site
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
17
AN ENVIRONMENT CONDUCIVE TO INNOVATION
UNIVERSITY BASED TECHNOLOGY TRANSFER ORGANISATIONS
Univalor
● Accelerating the transfer of the results of research, conducted by researchers at the University of Montreal and its schools and most of its affiliated hospitals, to industry
● Achievements : 10 active spin-offs, $1,5 million in third party investment in spin-offs, 460 000 $ grant to spin-offs, 139 patents and 178 patent applications in progress
Web site
Gestion Valeo
● To commercialize the results of research carried out by the member universities of the INRS-Université du Québec network
● In Montréal: École de technologie supérieure (ETS), l’Université du Québec à Montréal (UQAM), l’INRS-Institut-Armand Frappier
● 5 spin-out companies (2 in LSHT)
Web site
MSBi Valorisation (MSBiV)
● Provides capital, manpower and business sense to monetize promising technologies developed within: McGill University Université de Sherbrooke Bishop’s University As well as from affiliated hospitals and
research centers
● Since 2001: 12 spin-out companies (6 in LSHT) 3,3 M$ invested in tech transfer and spin
out companies Leverage factor above 50
Web site
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
18
AN ENVIRONMENT CONDUCIVE TO INNOVATION
THE QUEBEC NATIONAL POLICYON RESEARCH AND INNOVATION (PNRI)
The Government of Québec presents its new innovation policy in October 2013
· The Politique nationale de la recherche et de l’innovation (PNRI) confirms the support offered by the Government of Quebec to different components of R&D and of the innovation process including continuing support to innovative companies and to the commercialisation of research
A comprehensive innovation strategy while maintaining key programs
· A plan for investing $ 3,7 billion over 5 years
· Seven high priority fields of activities including the following two in LSHT:
biotechnologies and personalized healthcare
· Continuing support to SR&ED tax credits, one of the most competitive programs in the world
· Incentives to innovative companies: support for first patent application, to hiring graduates in their first research jobs, to start-up companies
· Increased financial support to university research funds along with long term commitment
· Increased budget for the College Technology Transfer Centers (CCTT)
CCTT in health technologies and related areas
· Centre de développement des composites du Québec (CDCQ): www.cdcq.qc.ca
· Centre de solutions technologiques en orthèses et prothèses (CSTOP): www.cstop.ca
· Institut international de logistique de Montréal – IILM: www.iilm.ca
· Vestechpro – Centre de recherche et d’innovation en habillement: www.vestechpro.com
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
19
AN ENVIRONMENT CONDUCIVE TO INNOVATION
A HOT SPOT OF OPEN INNOVATIONAND COLLABORATIVE RESEARCH
Incentives to collaborative research (Government of Québec)
· Tax credits at the applicable rate1 : on 80% of eligible expenditures in connection with a research contract with a university or
an eligible research center on half of the fees paid to a subcontractor at arm’s length who performed R&D on behalf of
the corporation in Québec on contribution paid to a research consortium or expenditures made in connection with pre-
competitive research project based on a private partnership
· Creation and funding of formal research consortia, by sector, to promote pre-competitive research and enhance the transfer of knowledge between public labs and companies
MEDTEQ - Le consortium de recherche industrielle et d’innovation en technologies médicales du Québec Web site
· Mission: to accelerate the development of new medical technologies for the benefit of clinicians and patients; validate their contribution to healthcare systems and their positioning on international markets
· Aims at facilitating networking between partners of the innovation process in med tech
· Targets inter-sectorial multidisciplinary projects, involving several partners (minimum of two companies and one public laboratory)
· Matches amounts invested by private companies up to 25% of the project costs
1 : «Taxation in Québec», Invest-Québec http://www.invest-quebec.com/documents/int/publications/FiscaliteQC2013_en.pdf
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
20
GREATER MONTREAL,
A LEADING VENTURE CAPITAL CENTER IN CANADA
Réseau Capital
· The only private equity association that brings together all stakeholders involved in the Quebec investment chain - Web site
Key statistics
· Between 2001 and 2011, venture capital investments in Montreal-based companies of the LSHT sector exceeded 1,6 G$. The region collected near 33% of the Canadian total – the highest in Canada for this sector.1
· Investments from venture capital funds are coming back in Quebec as shown by the following indicators 2 : In 2012, VC funds raised the highest amount of capital in 10 years (924 M$) 433 M$ were invested during the first half of 2013 in all sectors 41% of all funds available in Canada for the LSHT sector are to be found in Montreal
● In September 2013, BDC Venture Capital3 allocated $135 million in new capital to direct venture investments in innovative healthcare technology companies
1 : Profil_svts2013-1.pdf de www.montreal-invivo.com ; Thomson Reuters, 20122 : http://reseaucapital.com/nouvelles.php 3 http://www.bdc.ca/FR/solutions/capital_risque/salle_nouvelles/Pages/default.aspx#.Um6C2BBcnp4
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
21
TARGETED AND
HIGHLY COMPETITIVE INCENTIVES
Tax burden on business in R&D: almost 5 times less than the average of 19 other major North American cities
Cost-benefit due to R&D Tax credit
Mon
tréal
Toron
to
Minn
eapo
lis
Atlant
a
Phoen
ix
Détro
it
Clevela
nd
Miam
i
San D
iego
Bosto
n
Seattl
e
Los
Angele
s
San F
ranc
isco
Denve
r
New Y
ork
Chicag
o
Was
hingt
on
Dallas
Houst
on
Philad
elphie
0
20
40
60
80
100
120
Index of overall tax burden, average for R&D sectors(average of cities located in the United States = 100)
Top 20 largest cities in North America, 2012
N.B. : Exchange rate 1 $ US = 1 $ CARefer to Appendix 6 for methodology - Source : KPMG, 2012
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
22
Tax credit for scientific research and development
15 % allocated by the government of Canada and 17.5% by government of Quebec (the latter being refundable)
Scenario ($) No1Scientific research and experimental development (SR&ED), 2011
HYPOTHESIS1
The company is private under foreign control
20 eligible employees @ 50 000 $/year
100 % of their work is eligible
Subcontractor : 200 000 $
Equipment : 150 000 $
FEDERAL QUEBEC TOTAL
Salary ($) 1 000 000 1 000 000
Proxy method for overhead @ 55 % 550 000
Subcontractors2 160 000 100 000
Equipments 150 000
SR&ED credit of Quebec3 -192 500
1 517 500 1 100 000 554 000
Federal credit @ 20 % and Quebec credit @ 17,5 %
227 625 192 500 420 000
N.B. :1 This model considers the recent changes to the tax credit for scientific research and development (2012) and
therefore is valid from the 2014 fiscal year.2 Only 80% federal and 50% in Quebec of the amount paid to the subcontractor is eligible for the credit.3 In calculating the combined credit, the rate of provincial tax credit is applied to reduce the federal tax credit.
Source : Deloitte, Tax Incentive Programs in Québec – IT, January 2011
TARGETED AND
HIGHLY COMPETITIVE INCENTIVES(CONT’D)
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
23
Tax holiday for researchers and international experts
Tax exemption on taxable income in Quebec for a period of five years:
1st - 2nd years : 100 %3rd : 75 %4th : 50 %5th : 25 %
Financial assistance for job creationand training
25 % of eligible costs for implantation of training plans and 50 % of the costs for setting up a management service of human resources
And more…
TARGETED AND
HIGHLY COMPETITIVE INCENTIVES (CONT’D)
24
MONTREAL INTERNATIONAL : CUSTOMIZED SERVICES
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
25
MONTREAL INTERNATIONAL :
CUSTOMIZED SERVICES
Strategic support for different projects (implementation, expansion or strategic alliances)
Knowledge of financial and tax programs
Assistance to expatriates in their approaches to obtain official documents
Access to specialized professionals in knowledge-based sectors
Assistance in the selection of investment site via a comprehensive range of key comparative data
Linking with strategic actors of Greater Montreal
380, rue Saint-Antoine OuestBureau 8000Montréal (Québec) H2Y 3X7
Téléphone : 514 987-8191Télécopieur : 514 987-1948
www.montrealinternational.com
Business in Greater Montréal – Montréal International
@MontrealIntl@IntlOrgMontreal@talentmontreal
CONTACTMs. Ginette Audet, Ec. D.
DIRECTOR, BUSINESS DEVELOPMENT
INVESTMENT GREATER MONTREAL
Life Sciences
Office : 514 987-9379Cellular : 514 862-2978
27
APPENDICES
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
28
AN
NE
XE
S
APPENDIX 1 : PRESENTATION OF MONTREAL-IN-VIVO - CLUSTER OF LSHT- Multinational pharmaceutical companies with Canadian headquarters in the Montreal area as AbbVie , Bristol -Myers Squibb Canada , GlaxoSmithKline, Abbott Laboratories, Merck Canada , Novartis Pharmaceuticals Canada , Pfizer Canada , Sanofi and Servier Canada Business.
- Greater Montréal’s health technologies industry: consisting Innovative, international-calibre companies such as Covidien, Elekta, Medtronic of Canada, TELUS Health Solutions, Zimmer CAS, etc. and a large number of locally based and highly creative SMEs such as Carré Technologies, Emovi, Kinova, etc..
- Biotechnology : number of companies with headquarters in Montreal as AlethiaBiotherapeutics , Bio- K Plus International Caprion, MethylGene, Theratechnologies, Vertex Pharmaceuticals (Canada).
- Contract manufacturing research: offering a complete array of services ranging from preclinical studies to therapeutic drug monitoring in compliance with Good Manufacturing Practices (GMP); among which: Algorithme Pharma Cato Recherche Canada COREALIS Pharma Inc. Laboratoires Charles River Services Précliniques Montréal Laboratoires ITR Canada Quintiles Canada Recherche Clinique ICON (Canada) Uman Pharma.
- Greater Montréal, a natural bridge between North America and Europe and an ideal location for companies looking to expand into foreign markets: In 2012, Greater Montréal’s LSHT industry exported over $820 million worth of goods. Between 2006 and 2012, the region’s LSHT exports represented $5 billion.
Source :Profil_svts2013-1.pdf from www.montreal-invivo.com , with the collaboration of Montreal International
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
29
AN
NE
XE
S
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES
Company Web site Field of activity
AMD Ritmed Dressings, OR supplies and specialty surgical products
Analogic Canada Digital mammography imaging systems and flat panel detectors
atms Traceability solutions for the reprocessing of medical devices and OR linens in healthcare facilities
Bavaria Medical Technology Canada Catheters
Baylis Medical Company Supplier of high-technology cardiology, endovascular and oncology devices
bioMérieux Canada Diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination
Biomod Vectorization technologies for the delivery of active ingredients via the skin
Biomomentum Solutions for the biomechanical evaluation of tissues, biomaterials, and cartilage
Biotonix Imaging system for postural analysis to ensure optimal spinal health and overall fitness
Bracco Imaging Canada Contrast agents and solutions for medical imaging systems
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
30
AN
NE
XE
S
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company Web site Field of activity
Cardinal Health Canada Distributor of medical and surgical products
Carré Technologies Software and devices to monitor and record biosignals for real-time or delayed analysis
Citagenix Devices and materials for bone regeneration
Clemex Technologies Scientific image analysis solutions for quantitative microscopy
CogniSens Devices for measuring, identifying and improving neurobiological activity
ConvaTec Devices and supplies for stomacare, wound therapeutics and skin care
Coroneo Medical devices for the field of cardiac surgery
Covidien Distributor of medical devices and medical supplies
DenPlus Designs, manufactures and distributes dental products
Dymedso Introduction of new medical technologies to help those suffering from chronic respiratory diseases
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
31
AN
NE
XE
S
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company Web site Field of activity
Elekta Canada Systems for image guided radiation therapy of soft tissues using latest generation, 3-D ultrasound technology
EMcision Medical devices based on proven RF technology for the surgical community, endoscopists and interventional radiologists
emd Technologies High-voltage advanced power electronics components targeted at the medical X-ray field
Emovi System for dynamic 3D evaluation of knee motion
Ergoresearch Markets “intelligent” foot orthotics and specialty orthotics as well as software for the orthopedics; runs a network of orthotics clinics
Fresenius Medical Care Devices and supplies for kidney dialysis
Gambro Products and therapies for kidney and liver dialysis
Genia Photonics Laser based solutions and cost effective photonics for medical imaging
Héma-Québec Supplies safe, optimal blood components, substitutes, human tissues and cord blood to meet the needs of Quebec population
Invacare Canada Devices, equipment and products for rehab and home care
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
32
AN
NE
XE
S
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company Web site Field of activity
Kinova Robotics Six-axis robotic manipulator arm with a three-fingered hand for persons with upper body mobility impairment
Klox Technologies Therapeutic and cosmetic solutions based on a biophotonics system coupled with a light-trapping gel
Laborie Medical Technologies Innovative medical equipment and catheters in urology and gynecology
Lantheus Medical Imaging Diagnostic medical imaging agents and reagents
Maetta Specialized in powder injection molding for implants and orthopedic instruments
Masimo Canada Manufactures innovative noninvasive patient monitoring technologies, medical devices and a wide array of sensors
Medical Plastic Devices Provides precision injection molding services to the healthcare industry
MIT Canada Manufacturing and marketing of needle free jet injectors for veterinary and human applications
Medtronic Cryocath Catheter-based cryotherapy products to treat cardiovascular diseases
MedXL Designs and manufactures medical devices and prefilled syringes
Menodys Market innovative medical devices for improved health care
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
33
AN
NE
XE
S
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company Web site Field of activity
NexPlasmaGen Portable plasma-based medical instruments for wound healing and skin treatments
Noveko International Antimicrobial surgical masks, respirators and air filters derived from its patented antimicrobial filtration technology
Octostop Filters for X-ray procedures and systems for pediatric immobilisation
Oligo Medic Injectable gels for joint and cartilage repair
Optina Diagnostics Ocular imaging system based on super-spectral analysis
pDevices Miniature portable plasma based medical diagnostic device
Pega Medical Orthopedic instrumentation and pediatric implants
Photon etc. Application of hyperspectral analysis to ophtalmology and dermatology
Piramal Healthcare Innovation Products based on a biopolymer technology platform for enhancing the process of cartilage regeneration
Positech Innovation Cushions, and postural aid systems for to improve clients’ posture while providing them with maximum comfort and autonomy
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
34
AN
NE
XE
S
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company Web site Field of activity
QSD Manufacture of seamless compression apparel for post surgical recovery devices, athletic wear and orthopedic garments
Rheolution Instruments for the analysis of materials mechanical performance for biomedical applications and the study of biological tissues
Roche Diagnostics Canada Range of rapid, reliable instruments and tests for disease screening and diagnosis in laboratories, at the point of care, and for patient self-management
Rogue Research Neuronavigation products for application in the fields of cognitive neuroscience, rehabilitation research and veterinary sciences
SCIREQ Design and manufacture of precision laboratory equipment and data monitoring systems for preclinical pulmonary research
Smith & Nephew Diversified medical technology company
Surgmed Manufacturing and distribution of medical supplies and surgical products
Synergie Médicale BRG Automated dispensing system for solid oral medication
Thought Technologies Manufacturer of instruments for biofeedback, neurofeedback, and psychophysiological studies
ZimmerCAS Computer assisted surgical navigation system based on the Orthosoft platform to improve the outcomes of knee and hip replacement surgery
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
35
AN
NE
XE
S
APPENDIX 2 : COMPANIES
e-HEALTH & TELEMEDICINE
Company Web site Field of activity
Aptimed e-learning platform for health professionals in Canada and abroad
Bell Solutions Santé Portal for accessing computerized medical records and for the management of chronic diseases; development of mobile clinical carts for tele-health applications.
CAE Santé Patient simulators, surgical simulators, imaging simulators and courseware for healthcare professionals
Christie Innomed IT clinical systems and products related to medical imaging
Fujitsu Canada Services, equipment and software to improve the delivery of healthcare services
Groupe CGI Integrator of computerized management systems with applications to the healthcare sector
Intelerad Supplier of archiving and image transmission system (PACS) as per DICOM standards
Logibec Business software and computer services for the healthcare and social services sectors
Manyeta Home-base patient monitoring system which allows systemic monitoring of the patient’s metabolic condition
McKesson Canada A complete range of solutions to improve quality, security and cost for patient’s care
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
36
AN
NE
XE
S
APPENDIX 2 : COMPANIES
e-HEALTH & TELEMEDICINE (Cont’d)
Company Web site Field of activity
MediSolution Administrative software designed specifically to meet the operating data of laboratory computerization needs
Omnimed Software for the patient’s electronic record including speedy access and management of clinical data
PeriGen Provider of fetal surveillance software and systems
PHD Medical Products and services to meet specific needs of the home diagnostic and telemedicine markets
Purkinje Data management systems for healthcare centers
Shimadzu Software Development Canada
Development and maintenance of DICOM compliant medical software and image processing methods for the company’s cardiology and RF platforms
SOGIQUE Branch of the MSSS to support the management of Quebec healthcare computer network
TELUS Santé Specialized telecommunication services for electronic medical files; OASIS transmission systems for laboratory analyses
Vigilent Telesystems Software and robotic camera systems used in telemedicine, in teletraumatology and patient’s remote monitoring
ZoomMed A clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
37
AN
NE
XE
S
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche – Centre hospitalier de l’Université de Montréal (CHUM)
http://crchum.com/crchum.fr.html
Contact : Jacques Turgeon, Directeur
Centre de recherche – Centre universitaire de santé de McGill (CUSM)
http://cusm.ca/research/dashboard
Contact : Vassilios Papadopoulos,, D. Pharm., Ph.D., Directeur exécutif et scientifique en chef
Centre de recherche – CHU Sainte-Justine
http://www.chu-sainte-justine.org/recherche/
Contact : Alain Moreau, Ph.D., Directeur de la recherche
Centre de recherche Fernand-Seguin – Institut universitaire en santé mentale de Montréal
http://www.iusmm.ca/recherche.html
Contact : Sonia Lupien, Ph.D., Directrice scientifique
Centre de recherche - Hôpital général juif – Institut Lady Davis de recherches médicales
http://ladydavis.ca/fr/home
Contact: Roderick R. McInnes, MD, PhD, Directeur
Centre de recherche – Hôpital Maisonneuve-Rosemont
http://recherche.maisonneuve-rosemont.org/
Contact : Denis Claude Roy, M.D., Directeur
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
38
AN
NE
XE
S
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche - Hôpital de Montréal pour enfants
http://www.hopitalpourenfants.com/la-recherche
Contact : Jacquetta Trasler, M.D., Ph.D., Directrice, recherche en santé de l’enfant
Centre de recherche – Hôpital du Sacré-Cœur de Montréal
http://www.crhscm.ca/
Contact : François Madore, M.D., Directeur de la recherche
Centre de recherche – Institut et hôpital neurologiques de Montréal
http://francais.mni.mcgill.ca/
Contact : Guy A. Rouleau, M.D., Ph.D., Directeur
Centre de recherche – Institut Philippe-Pinel de Montréal
http://www.pinel.qc.ca/GeneralList.aspx?NavID=293&CultureCode=fr-CA
Contact : Gilles Côté, Ph.D., Directeur
Centre de recherche – Institut de cardiologie de Montréal
http://www.icm-mhi.org/fr/recherche/propos-centre-recherche Contact : Jean-Claude Tardif, M.D., Directeur
Centre de recherche - Institut universitaire de gériatrie de Montréal (CRIUGM)
http://www.criugm.qc.ca/
Contact : Sylvie Belleville, Ph.D. Directrice scientifique
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
39
AN
NE
XE
S
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche - Institut universitaire en santé mentale Douglas
http://www.douglas.qc.ca/
Contact : Brigitte L. Kiefer, Ph.D., Directrice scientifique
Centre de recherche interdisciplinaire en réadaptation du Montréal métropolitain (CRIR)
http://www.crir.ca/?84879747-0EEE-4FA6-878C-B927C1EA76A4 Contacts :Eva Kehayia & Bonnie R. Swaine, Directrices scientifiques
Institut de réadaptation Gingras-Lindsay-de-Montréal (IRGLM)
http://www.irglm.qc.ca/recherche/la-recherche-a-lirglm.php
Contact :Lise Poissant, Directrice de la recherche
Institut de recherche clinique de Montréal (IRCM)
http://www.ircm.qc.ca/IRCM/Pages/default.aspx?PFLG=1036&lan=1036
Contact : Dr Tarik Möröy, Ph.D., Président et directeur scientifique
Institut de recherche Robert-Sauvé en santé et en sécurité du travail du Québec (IRSST)
http://www.irsst.qc.ca/
Contact : Marie Larue, Présidente-directrice générale
Institut du cancer de Montréal (ICM)
http://www.icm.qc.ca/cgi-cs/cs.waframe.index?lang=1
Contact : Anne-Marie Mes-Masson, Ph.D., Directrice scientifique
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
40
AN
NE
XE
S
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche en sciences et technologies biomédicales (GRSTB)
http://www.groupes.polymtl.ca/grstb/
Contact : Michael D. Buschmann, B.Eng., Ph.D., Directeur; [email protected]
Centre PERFORM de l’Université Concordia
http://performcentre.concordia.ca/fr/
Contact : Kevin Little, Directeur général; [email protected]
Département de génie biomédical de McGill
http://www.bmed.mcgill.ca/
Contact: Robert E. Kearney, Président du département; [email protected]
Institut de génie biomédical
http://www.igb.umontreal.ca/
Contact : Pierre Savard, Directeur; [email protected]
Laboratoire de recherche en imagerie et orthopédie (LIO)
http://www.etsmtl.ca/Unites-de-recherche/lio/accueil
Contact : Jacques A. de Guise, Ph.D., ing. Titulaire; [email protected]
Laboratoire d'imagerie, de vision et d'intelligence artificielle (LIVIA)
http://www.etsmtl.ca/Unites-de-recherche/LIVIA/accueil
Contact : Robert Sabourin, Directeur; [email protected]
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
41
AN
NE
XE
S
APPENDIX 4 : RESEARCH CHAIRS
Chaire industrielle de recherche en technologies intra-auriculaires Sonomax-ÉTS – CRITIAS
http://www.etsmtl.ca/Recherche/Chaires-unites-rech/Chaires/Chaire-CRITIAS
Contact : Jérémie Voix, Titulaire; [email protected]
Chaire de recherche du Canada en imagerie 3D et ingénierie biomédicale
http://chairei3dib.etsmtl.ca/
Contact : Jacques A. de Guise, Ph.D., Ing., Titulaire; [email protected]
Chaire de recherche du Canada sur les biomatériaux et implants endovasculaires
http://www.etsmtl.ca/Chaires-de-recherche/Chaire-biomateriaux/Accueil?lang=fr-CA
Contact : Sophie Lerouge, MÉC, Titulaire; [email protected]
Chaire de recherche Marie-Lou et Yves Cotrel en orthopédie du CHUM et de l'Université de Montréal (Soutenue par la Fondation de l'ÉTS)
http://en.etsmtl.ca/Unites-de-recherche/LIO/Recherche-et-innovation/Chaires
Contact : Jacques A. de Guise, Ph.D., Ing., Titulaire; [email protected]
Chaire de recherche ÉTS en traumatologie vertébro-médullaire
http://www.etsmtl.ca/Recherche/Chaires-unites-rech/Chaires/CRI-traumatologie
Contact : Yvan Petit, Titulaire,; [email protected]
SE
CT
OR
|
ME
DIC
AL
TE
CH
NO
LOG
IES
42
AN
NE
XE
S
APPENDIX 4 : RESEARCH CHAIRS
Chaire de recherche du Canada en communications sans fil à haute vitesse
http://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-fra.aspx?profileId=803
Contact : Sofiène Affes, Titulaire; [email protected]
Chaire de recherche du Canada en photonique ultrarapide appliquée aux matériaux et aux systèmeshttp://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-fra.aspx?profileId=60
Contact : Jean-Claude Kieffer, Titulaire; [email protected]
Chaire de recherche du Canada en plasmas appliqués aux technologies de micro et de nanofabrication
http://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-fra.aspx?profileId=817
Contact: Mohamad Chaker, Titulaire; [email protected]
Chaire de recherche du Canada en technologies de l’information dans le secteur de la santé (HEC Montréal)
http://neumann.hec.ca/chairetisante/index2.html
Contact : Guy Paré, Ph.D. Titulaire; [email protected]
Chaire de recherche du Canada sur les Innovations en santé
http://www.medsp.umontreal.ca/crcinnovations/
Contact : Pascale Lehoux, Titulaire; [email protected]
Chaire de recherche du Canada sur les dispositifs médicaux intelligents (DMI)
http://www.polymtl.ca/recherche/rc/unites/details.php?NoUnite=119
Contact: Mohamad Sawan, Titulaire; [email protected]
